title: Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
authors.affiliation: Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Ferrara
authors.forename: Octavian R
authors.initials: OR
authors.lastname: Adam
authors.forename: William G
authors.initials: WG
authors.lastname: Ondo
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects; D001284:Atrophy / Q000209:etiology / Q000473:pathology; D003866:Depressive Disorder / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000150:complications / Q000503:physiopathology* / Q000523:psychology; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D012249:Rhombencephalon / Q000473:pathology / Q000503:physiopathology; D020754:Spinocerebellar Ataxias / Q000150:complications* / Q000473:pathology
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa